Keros Therapeutics, Inc.

KROS·NasdaqGM·Healthcare
Compare
10.830.00 (0.00%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close10.83
Open11.13
Day range10.8011.15
52-week range9.6922.55
Off day high−2.87%
Off 52-week high−51.97%
Volume128.26K
Avg. volume (3M)185.87K
Market cap214.73M
EPS (TTM)-3.22
Forward P/E-1.64
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.19
Shares outstanding19.83M
Short interest6.59% of float
Earnings dateNov 5, 2026 (est.)
Analyst target19.83
Profit margin0.00%

Against its peers

Compare in full ›
KROS AVBP GERN AGMB ZVRA DSGN
Market cap 214.73M 665.16M 693.87M 337.35M 663.32M 665.24M
P/E (TTM) — — — — 9.2 —
Forward P/E -1.6 -3.6 27.0 -3.4 10.4 -6.6
Price/book 0.8 1.8 3.1 2.7 4.1 3.0
Dividend yield — — — — — —
1-year change −30.80% −28.97% −14.68% −53.24% +1.89% +57.86%
Today 0.00% +3.61% +16.13% 0.00% +8.87% +2.80%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All KROS news ›

From the 4Search news index, newest first.

In the news

11mentions in 30 days
9with it in the headline
Negativesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance